Breast cancer
Progression after CDK4/6i + ET for HR+ HER2- MBC. What now?Tracy (72 years old)
Tracy, 72 years old former actress, enjoys sitting by the fire in her cosy living room, tracing old script notes with a wistful smile.
She was diagnosed with metastatic breast cancer 3 years ago, after she had been treated for early HR+ HER2- breast cancer 12 years ago.
Assessment summary:
- Postmenopausal
- No family history of breast cancer
- ECOG PS: 0
- Medical history:
- HR+ HER2- breast cancer T2N0M0 12 years ago. Treated with breast conserving surgery, radiation therapy and letrozole for 5 years
- Diagnosis metastatic disease 3 years ago (bones, liver). Biopsy of liver metastasis: breast cancer, NST, ER 90%, PgR 60%, HER2 IHC 1+, G2. Treatment with abemaciclib + anastrozole was started
- Tumour regression in control imaging
- Most recent CT scan of chest and abdomen and bone scan:
- Stable multiple bone metastases
- Progression of 2 liver metastases
- Haematology and biochemistry: all values normal
- Somatic PIK3CA mutation status: wild type
- Somatic ESR1 mutation status (on liquid biopsy): wild type
- Germline BRCA mutation status: BRCA1 mutation